Hims & Hers Health's upcoming Q2 2026 earnings call on August 10 follows a Q1 report showing $608 million in revenue (up just 4% year-over-year and missing estimates) alongside subscriber growth to nearly 2.6 million. The telehealth platform's shift toward branded GLP-1 weight-loss treatments pressured margins and U.S. sales while international expansion via acquisitions like Zava boosted results, prompting raised full-year revenue guidance to $2.8–3.0 billion but lowered EBITDA targets. Traders are watching for updates on peptide offerings, branded drug momentum, and cost discipline amid competitive pressure in digital health and personalized wellness solutions.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоWhat will Hims say during their next earnings call?
What will Hims say during their next earnings call?
НОВЕ
Aug 10, 2026
Quarter 20+ times
95%
Subscriber 15+ times
78%
Platform 10+ times
95%
Fiscal 10+ times
4%
Peptide 5+ times
61%
GLP-1
95%
Testosterone
93%
Eucalyptus
89%
Longevity
80%
Wearable
73%
Europe
58%
Amazon
26%
Regulation
26%
-No Qualifying Event-
6%
$385 Обс.
Quarter 20+ times
$38 Обс.
95%
Subscriber 15+ times
$0 Обс.
78%
Platform 10+ times
$52 Обс.
95%
Fiscal 10+ times
$60 Обс.
4%
Peptide 5+ times
$0 Обс.
61%
GLP-1
$0 Обс.
95%
Testosterone
$0 Обс.
93%
Eucalyptus
$0 Обс.
89%
Longevity
$0 Обс.
80%
Wearable
$71 Обс.
73%
Europe
$61 Обс.
58%
Amazon
$0 Обс.
26%
Regulation
$0 Обс.
26%
-No Qualifying Event-
$103 Обс.
6%
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdfHims & Hers Health's upcoming Q2 2026 earnings call on August 10 follows a Q1 report showing $608 million in revenue (up just 4% year-over-year and missing estimates) alongside subscriber growth to nearly 2.6 million. The telehealth platform's shift toward branded GLP-1 weight-loss treatments pressured margins and U.S. sales while international expansion via acquisitions like Zava boosted results, prompting raised full-year revenue guidance to $2.8–3.0 billion but lowered EBITDA targets. Traders are watching for updates on peptide offerings, branded drug momentum, and cost discipline amid competitive pressure in digital health and personalized wellness solutions.
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
Ринок відкрито: Aug 7, 2026, 7:02 PM ET
Обсяг
$385Дата завершення
Aug 10, 2026Ринок відкрито
Aug 7, 2026, 7:02 PM ETResolver
0x65070BE91...This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdfHims & Hers Health's upcoming Q2 2026 earnings call on August 10 follows a Q1 report showing $608 million in revenue (up just 4% year-over-year and missing estimates) alongside subscriber growth to nearly 2.6 million. The telehealth platform's shift toward branded GLP-1 weight-loss treatments pressured margins and U.S. sales while international expansion via acquisitions like Zava boosted results, prompting raised full-year revenue guidance to $2.8–3.0 billion but lowered EBITDA targets. Traders are watching for updates on peptide offerings, branded drug momentum, and cost discipline amid competitive pressure in digital health and personalized wellness solutions.
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
Обсяг
$385Дата завершення
Aug 10, 2026Ринок відкрито
Aug 7, 2026, 7:02 PM ETResolver
0x65070BE91...Hims & Hers Health's upcoming Q2 2026 earnings call on August 10 follows a Q1 report showing $608 million in revenue (up just 4% year-over-year and missing estimates) alongside subscriber growth to nearly 2.6 million. The telehealth platform's shift toward branded GLP-1 weight-loss treatments pressured margins and U.S. sales while international expansion via acquisitions like Zava boosted results, prompting raised full-year revenue guidance to $2.8–3.0 billion but lowered EBITDA targets. Traders are watching for updates on peptide offerings, branded drug momentum, and cost discipline amid competitive pressure in digital health and personalized wellness solutions.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання